A positive correlation has been found between increased CXCL10 expression and improved prognosis in various human cancers, including CRC, esophageal squamous cell carcinoma, hepatocellular carcinoma and breast cancer [16, 45, 46, 47]. Here, CXCL10 is linked to esophageal squamous cell carcinoma.